• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

趋化因子在与达菲抗原-红细胞趋化因子受体结合方面的类别差异。

Chemokine class differences in binding to the Duffy antigen-erythrocyte chemokine receptor.

作者信息

Szabo M C, Soo K S, Zlotnik A, Schall T J

机构信息

Department of Pathology, Stanford University School of Medicine, California 94305, USA.

出版信息

J Biol Chem. 1995 Oct 27;270(43):25348-51. doi: 10.1074/jbc.270.43.25348.

DOI:10.1074/jbc.270.43.25348
PMID:7592697
Abstract

The Duffy blood group antigen-erythrocyte chemokine receptor has been shown to bind to chemokines of both the C-X-C and C-C classes and to the malarial parasites Plasmodium vivax and Plasmodium knowlesi. We performed experiments to evaluate the binding properties of this receptor for the newly appreciated "C" and "non-ELR C-X-C" classes of chemokines. Binding to mouse erythrocytes was also evaluated for the first time. Whereas ELR C-X-C and C-C chemokines bound to human erythrocytes with high affinity, differences in the ability of non-ELR chemokines to act as competitive inhibitors were noted. While non-ELR chemokines were unable to displace C-X-C chemokines on human cells, they exhibited a low affinity interaction with the C-C chemokine binding site. The newly discovered C chemokine, lymphotactin, was unable to displace either C-X-C or C-C chemokines. On mouse erythrocytes, non-ELR chemokines exhibited a low affinity for both the C-X-C and C-C chemokines binding sites; again lymphotactin failed to bind. Binding competition studies using an anti-Duffy monoclonal antibody and chemokines suggested a common binding domain. These data show that the chemokine superfamily has at least four functional subdivisions, each interacting differently with the Duffy antigen-erythrocyte chemokine receptor. In addition the chemokine binding function is conserved between mouse and man. Unlike other proteins in the superfamily C and non-ELR C-X-C chemokines do not efficiently bind red blood cells, thus their role may not require clearance from circulation.

摘要

达菲血型抗原-红细胞趋化因子受体已被证明可与C-X-C和C-C两类趋化因子以及疟原虫间日疟原虫和诺氏疟原虫结合。我们进行了实验以评估该受体对新发现的“C”类和“非ELR C-X-C”类趋化因子的结合特性。还首次评估了其与小鼠红细胞的结合情况。虽然ELR C-X-C和C-C趋化因子以高亲和力与人红细胞结合,但注意到非ELR趋化因子作为竞争性抑制剂的能力存在差异。虽然非ELR趋化因子无法在人细胞上取代C-X-C趋化因子,但它们与C-C趋化因子结合位点表现出低亲和力相互作用。新发现的C趋化因子淋巴细胞趋化因子无法取代C-X-C或C-C趋化因子。在小鼠红细胞上,非ELR趋化因子对C-X-C和C-C趋化因子结合位点均表现出低亲和力;淋巴细胞趋化因子同样未能结合。使用抗达菲单克隆抗体和趋化因子进行的结合竞争研究表明存在一个共同的结合域。这些数据表明趋化因子超家族至少有四个功能亚群,每个亚群与达菲抗原-红细胞趋化因子受体的相互作用不同。此外,趋化因子结合功能在小鼠和人之间是保守的。与超家族中的其他蛋白质不同,C类和非ELR C-X-C趋化因子不能有效地结合红细胞,因此它们的作用可能不需要从循环中清除。

相似文献

1
Chemokine class differences in binding to the Duffy antigen-erythrocyte chemokine receptor.趋化因子在与达菲抗原-红细胞趋化因子受体结合方面的类别差异。
J Biol Chem. 1995 Oct 27;270(43):25348-51. doi: 10.1074/jbc.270.43.25348.
2
The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes.达菲血型抗原上用于间日疟原虫和诺氏疟原虫疟原虫与红细胞结合的结构域。
J Exp Med. 1996 Oct 1;184(4):1531-6. doi: 10.1084/jem.184.4.1531.
3
A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor.间日疟原虫的一种受体:红细胞趋化因子受体。
Science. 1993 Aug 27;261(5125):1182-4. doi: 10.1126/science.7689250.
4
The promiscuous chemokine binding profile of the Duffy antigen/receptor for chemokines is primarily localized to sequences in the amino-terminal domain.趋化因子的达菲抗原/趋化因子受体杂乱的趋化因子结合谱主要定位于氨基末端结构域的序列。
J Biol Chem. 1995 Nov 3;270(44):26239-45. doi: 10.1074/jbc.270.44.26239.
5
Expression of the Duffy antigen in K562 cells. Evidence that it is the human erythrocyte chemokine receptor.达菲抗原在K562细胞中的表达。证明其为人类红细胞趋化因子受体。
J Biol Chem. 1994 Mar 18;269(11):7835-8.
6
The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor.趋化因子的达菲抗原/受体(DARC)在缺乏红细胞受体的达菲阴性个体的内皮细胞中表达。
J Exp Med. 1995 Apr 1;181(4):1311-7. doi: 10.1084/jem.181.4.1311.
7
Identification and characterization of a promiscuous chemokine-binding protein in a human erythroleukemic cell line.人红白血病细胞系中一种多特异性趋化因子结合蛋白的鉴定与表征
J Biol Chem. 1994 Jul 1;269(26):17730-3.
8
A role of the Duffy antigen for the maintenance of plasma chemokine concentrations.达菲抗原在维持血浆趋化因子浓度方面的作用。
Biochem Biophys Res Commun. 2003 Mar 28;303(1):137-9. doi: 10.1016/s0006-291x(03)00293-6.
9
Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy blood group antigen.肾脏中的毛细血管后微静脉内皮细胞表达一种多特异性趋化因子受体,其在结构和功能上与红细胞同种型相同,而红细胞同种型即达菲血型抗原。
J Clin Invest. 1994 Sep;94(3):985-91. doi: 10.1172/JCI117465.
10
Sulphated tyrosines mediate association of chemokines and Plasmodium vivax Duffy binding protein with the Duffy antigen/receptor for chemokines (DARC).硫酸化酪氨酸介导趋化因子和间日疟原虫达菲结合蛋白与趋化因子达菲抗原/受体(DARC)的结合。
Mol Microbiol. 2005 Mar;55(5):1413-22. doi: 10.1111/j.1365-2958.2004.04478.x.

引用本文的文献

1
Investigating the interaction of ACKR1 and c-Myc in the breast carcinoma tumor microenvironment modulation.研究ACKR1与c-Myc在乳腺癌肿瘤微环境调节中的相互作用。
Discov Oncol. 2025 Aug 25;16(1):1615. doi: 10.1007/s12672-025-03437-8.
2
Molecular mechanism of distinct chemokine engagement and functional divergence of the human Duffy antigen receptor.人 Duffy 抗原受体结合不同趋化因子的分子机制及其功能分化。
Cell. 2024 Aug 22;187(17):4751-4769.e25. doi: 10.1016/j.cell.2024.07.005. Epub 2024 Jul 31.
3
Atypical chemokine receptors in the immune system.
免疫系统中的非典型趋化因子受体
Nat Rev Immunol. 2024 Oct;24(10):753-769. doi: 10.1038/s41577-024-01025-5. Epub 2024 May 7.
4
Bioinformatic Analysis of the CXCR2 Ligands in Cancer Processes.癌症进程中 CXCR2 配体的生物信息学分析。
Int J Mol Sci. 2023 Aug 27;24(17):13287. doi: 10.3390/ijms241713287.
5
The Clinical Significance and Role of CXCL1 Chemokine in Gastrointestinal Cancers.CXCL1 趋化因子在胃肠道癌中的临床意义和作用。
Cells. 2023 May 17;12(10):1406. doi: 10.3390/cells12101406.
6
New pairings and deorphanization among the atypical chemokine receptor family - physiological and clinical relevance.新型趋化因子受体家族配体及其孤儿受体的鉴定——生理和临床相关性。
Front Immunol. 2023 Apr 20;14:1133394. doi: 10.3389/fimmu.2023.1133394. eCollection 2023.
7
Involvement in Tumorigenesis and Clinical Significance of CXCL1 in Reproductive Cancers: Breast Cancer, Cervical Cancer, Endometrial Cancer, Ovarian Cancer and Prostate Cancer.CXCL1在生殖系统癌症(乳腺癌、宫颈癌、子宫内膜癌、卵巢癌和前列腺癌)发生中的作用及临床意义
Int J Mol Sci. 2023 Apr 14;24(8):7262. doi: 10.3390/ijms24087262.
8
Prospects for targeting ACKR1 in cancer and other diseases.靶向 ACKR1 在癌症和其他疾病中的应用前景。
Front Immunol. 2023 Mar 15;14:1111960. doi: 10.3389/fimmu.2023.1111960. eCollection 2023.
9
The DARC Side of Inflamm-Aging: Duffy Antigen Receptor for Chemokines (DARC/ACKR1) as a Potential Biomarker of Aging, Immunosenescence, and Breast Oncogenesis among High-Risk Subpopulations.炎症衰老的 DARC 方面:趋化因子 Duffy 抗原受体 (DARC/ACKR1) 作为高危亚人群衰老、免疫衰老和乳腺癌发生的潜在生物标志物。
Cells. 2022 Nov 29;11(23):3818. doi: 10.3390/cells11233818.
10
Magnesium homeostasis in deoxygenated sickle erythrocytes is modulated by endothelin-1 via Na /Mg exchange.缺氧状态下镰状红细胞内镁离子稳态由内皮素-1 通过钠/镁交换进行调节。
FASEB J. 2022 Dec;36(12):e22638. doi: 10.1096/fj.202201339R.